Viz.ai Ranked No. 1 for Second Consecutive Year in 2026 Black Book Survey of Independent AI Clinical Decision Support Solutions

April 9, 2026 7:30 AM

Black Book Research today announced that Viz.ai has been ranked No. 1 for the second consecutive year in its 2026 survey of independent AI Clinical Decision Support solutions, based on direct input from healthcare users across hospitals, health systems, medical groups, and clinical service-line operations. The annual report evaluates independent, non-EHR-embedded or native clinical AI and care coordination platforms on eighteen performance...

Read more

KLARA Beauty Makes U.S. Debut with Science-Driven Skincare

April 9, 2026 5:45 AM

KLARA Beauty launches in the U.S., bringing peptide-powered skincare to Los Angeles Fashion Week for radiant, science-backed results.Korean Skincare Innovation Lands in the U.S.KLARA Beauty, a next-generation skincare brand developed by Korea-based biotech company NIBEC, has officially debuted in the United States, introducing a new approach to everyday beauty that blends advanced peptide science with practical at-home application. Rooted in...

Read more

IRLAB to Present at Redeye Healthcare Day 2026

April 9, 2026 1:45 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will give a presentation at Redeye Health Care Day in Stockholm on April 14.Kristina Torfgård, CEO, will attend and present IRLAB at the event, held at Redeye's office, Mäster Samuelsgatan 42, in Stockholm."I am looking forward to presenting our leading portfolio in Parkinson's disease...

Read more

SerenaGroup Launches National HBOT Consulting Service to Help Hospitals Reclaim Control of Wound Care Programs

April 8, 2026 5:30 PM

Hospitals face mounting pressure to improve outcomes while reducing costs. SerenaGroup® has a novel solution for Wound Care and Hyperbaric Oxygen Services: Consulting Services. The goal is to improve outcomes and increase profitability without outsourcing operational control.The initiative, led by internationally recognized wound care expert Dr. Thomas Serena, aims to challenge the traditional model of wound care program management by empowering...

Read more

Washington's Hemp Shell Game: How Medicare Dollars Are Funding Non-Approved Products While FDA-Compliant Medicines Wait

April 8, 2026 4:06 PM

A quiet regulatory contradiction is unfolding in Washington, and it represents a profound threat to the integrity of the U.S. pharmaceutical system. While the Food and Drug Administration (FDA) maintains a strict "science-first" barrier for drug developers, the Centers for Medicare & Medicaid Services (CMS) has launched a parallel track that allows federal funding to flow toward unvalidated, retail-grade hemp products. The Substance Access...

Read more

Kansas Hospitals Positioned to Strengthen Rural Care Through Rural Health Transformation Program

April 8, 2026 2:43 PM

As the Kansas Department of Health and Environment rolls out the Rural Health Transformation Program across the state, Kansas hospitals have a timely opportunity to reimagine how care is delivered in rural communities.The Rural Health Transformation Program is designed to help stabilize and strengthen rural hospitals, improve access to care, and support long term sustainability through strategic funding and innovative care models. For many...

Read more

Action Behavior Centers Expands into Philadelphia, Opening Three New Centers to Serve Children Diagnosed with Autism

April 8, 2026 2:00 PM

Action Behavior Centers, a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), is expanding into the Philadelphia area with the opening of three new centers in Horsham, Newtown, and King of Prussia with no waitlists.This expansion brings increased access to high-quality autism services for families across the region, including center-based ABA therapy for children...

Read more

Drs. Todd H. Lanman and Joel S. Beckett Perform First Clinical Case Using Newly FDA-Approved Synergy Disc(R)

April 8, 2026 11:40 AM

Todd H. Lanman, MD, and Joel S. Beckett, MD have performed the first post-approval case using the newly FDA-approved Synergy Disc®, marking an early clinical milestone for the motion-preserving cervical disc technology. The procedure was performed on Monday at the Advanced Surgery Center of Beverly Hills five weeks after the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for the Synergy Disc® for single-level...

Read more

Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction

April 8, 2026 11:10 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the planned Q2 2026 U.S. launch of Liv18™, a next-generation liver health supplement powered by BergacynFF®, the only patented botanical blend clinically demonstrated to reduce liver fat accumulation and support healthy body weight in two independent randomized controlled trials.The Liver Fat...

Read more

DistillerSR Launches the Industry's Most Advanced GenAI Capabilities for Extracting Scientific Literature Evidence

April 8, 2026 10:00 AM

DistillerSR, the market leader in AI-enabled literature review automation and evidence management, today announced new fully automated capabilities for its Smart Evidence Extraction (SEE) module. SEE uses purpose-built GenAI to automate end‑to‑end workflows for extracting evidence from scientific literature at scale, while maintaining full auditability and human governance over AI‑generated outputs.As the volume of published research continues...

Read more

Medical Care Technologies (OTC Pink:MDCE) Expands AI Monetization Strategy and Advances Pipeline of AI Applications

April 8, 2026 9:10 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today announced the expansion of its monetization strategy for its AI-powered mobile application, Snapshot Recipes, while advancing development initiatives across its broader pipeline of AI-driven applications. As part of this initiative, the Company has begun exploring affiliate marketing partnerships designed to complement the existing Snapshot Recipes platform. These efforts are...

Read more

SpendMend Appoints Paul Kappelman as Chairman of the Board

April 8, 2026 9:00 AM

SpendMend, the leading provider of cost cycle management solutions to the healthcare industry, today announced the appointment of Paul Kappelman as Chairman of the Board.Kappelman is a seasoned healthcare executive with more than 30 years of leadership experience across hospitals, physician practices, ambulatory surgery centers, and other healthcare organizations. He has led multi-state and multi-site operations and brings extensive experience...

Read more

Apex Health Launches ApexAscent(TM): a Technology and Operating Platform to Power Physician Network Performance and Growth

April 8, 2026 9:00 AM

Apex Health, a leading provider enablement partner, today announced the official launch of ApexAscent™, a comprehensive operating platform designed to accelerate physician network performance and growth.Healthcare providers and regional payers should be able to access best-in-class value-based care services without sacrificing control of their clinical network assets and payer contracts. "Too often, providers seeking value-based care enablement...

Read more

Aetna Collaborates With Community Organizations To Strengthen Access to Quality Care and Essential Resources in Central Missouri

April 8, 2026 9:00 AM

Aetna Better Health of Missouri, a CVS Health company (NYSE:CVS), announced that Aetna provided a total of $35,000 in funding to two community-based organizations in central Missouri to improve access to health care and support child and family well being. The donations support community programs that directly address persistent barriers to care faced by rural communities, including long travel distances for medical services, limited...

Read more

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

April 8, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that the Company has completed the company's ongoing effectiveness study of crofelemer delayed-release tablets for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Crofelemer, under the name Canalevia-CA1, is currently conditionally approved for the sole indication of treating CID in dogs. The approval for Canalevia CA-1 will expire on December 21, 2026."We're very pleased...

Read more

Wiley's 'The Black Book of Reshoring' by Douglas Brown Debuts at No. 3 on Amazon's Business Bestsellers List

April 8, 2026 8:00 AM

Black Book Insights, a reshoring and manufacturing advisory and think tank, today announced that The Black Book of Reshoring: The Essential Guide to America's New Manufacturing Boom by founder Douglas Brown debuted at No. 3 on Amazon's Business Development Bestsellers List this past week. Published by Wiley on March 31, 2026, the book enters the market at a pivotal time for manufacturers, investors, policymakers, and economic development...

Read more

Envision Pharma Group appoints Nick Jones as President, Envision Medical Communications

April 8, 2026 8:00 AM

Envision Pharma Group (Envision), a global, technology-enabled solutions partner to the life sciences industry, today announced the appointment of Nick Jones as President, Envision Medical Communications (EMC). In this role, Jones will lead the EMC business, focusing on integrating Envision's industry-leading technology and AI capabilities into its award-winning portfolio of solutions and services.Jones joins the company from ConcertAI, where he...

Read more

Marijuana Rescheduling Countdown: Why the "Order of Operations" and Todd Blanche's Appointment Define the Path to Schedule III

April 8, 2026 6:30 AM

The transition of marijuana to Schedule III has entered its most critical phase: the final administrative "order of operations." Following President Donald J. Trump's historic December executive order and recent directives to Acting Attorney General Todd Blanche, the focus has shifted to the rigorous legal execution required to finalize the rule. For MMJ International Holdings, a leader in the FDA botanical drug development pathway, the current...

Read more

Rad Source Technologies Activates a Wealth of Peer-Reviewed Data with Bioz Badges to Strengthen Customer Use-Case Visibility

April 8, 2026 4:00 AM

Bioz, Inc., the leading scientific citation intelligence platform that transforms publications into measurable product validation and commercial impact, announced its collaboration with Rad Source Technologies, a global provider of advanced X-ray irradiation solutions for research and industrial applications. By embedding Bioz Badges across its product webpages, Rad Source is now surfacing peer-reviewed scientific validation to strengthen...

Read more

AlzeCure Pharma Publishes its Annual Report for 2025

April 8, 2026 2:15 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that its Annual Report for 2025 has been published."2025 was an active and positive year for AlzeCure Pharma. One of our main focus areas was to prepare the phase II study in Alzheimer's patients with NeuroRestore ACD856, for which we were awarded a...

Read more